Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding

Pia Gattinger, Kristina Borochova, Yulia Dorofeeva, Rainer Henning, Renata Kiss, Bernhard Kratzer, Bernhard Mühl, Thomas Perkmann, Doris Trapin, Martina Trella, Paul Ettel, Inna Tulaeva, Winfried F Pickl, Rudolf Valenta

Research output: Journal article (peer-reviewed)Letter/short communication

23 Citations (Scopus)
Original languageEnglish
Pages (from-to)878-883
Number of pages6
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume76
Issue number3
DOIs
Publication statusPublished - Mar 2021

Keywords

  • Adolescent
  • Adult
  • Aged
  • Angiotensin-Converting Enzyme 2/metabolism
  • Antibodies, Viral/blood
  • Binding Sites
  • COVID-19/diagnosis
  • Convalescence
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunoglobulin G/blood
  • Immunoglobulin M/blood
  • Male
  • Middle Aged
  • Receptors, Coronavirus/metabolism
  • SARS-CoV-2/immunology
  • Young Adult

Cite this